EVOQUE device trial for severe tricuspid regurgitation
Part of Heart & circulation clinical trials.
This study looks at how well the EVOQUE device works for people with Medicare who have severe tricuspid regurgitation (a leaky heart valve) or who might get the device. It helps doctors learn more about treating this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have Medicare insurance.
- You have already received the EVOQUE device or are eligible to receive it.
- You have at least severe tricuspid regurgitation (a severe leak in one of your heart valves).
- You do not have commercial insurance instead of Medicare.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a registry that collects information on patients who have had a minimally invasive procedure to fix a leaky tricuspid valve. By joining, you help doctors learn more about how well these devices work over time.
This study tests a device called TriClip to repair a leaky tricuspid valve in the heart. If the leak is reduced, you may have less shortness of breath and feel more energetic.
This trial tests a new catheter-based device to replace your tricuspid valve without open-heart surgery. It's for people with severe tricuspid regurgitation who are at high risk for surgery.
This study is testing whether the TriClip device helps people with severe tricuspid regurgitation (a leaky heart valve) feel better. It compares people who received the TriClip to those who didn't get the procedure.
This study follows adults with a severely leaky tricuspid heart valve who still have symptoms despite medication. It looks at outcomes after a procedure called TriClip, which helps reduce valve leakage.
This study is testing a new way to replace the tricuspid valve (the valve that controls blood flow from the heart's right upper chamber to the right lower chamber) without open-heart surgery. The goal is to see how safe and effective the EVOQUE valve is for people with a leaky tricuspid valve.
Hear when a new Tricuspid Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.